BMJ (British Medical Journal pubslished in October 9, 2012 edition a study of 1,006 health women age 45-58 recently menopausal or perimenopausal women followed for 10 years.  After 10years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure or myocardial infarction (heart attack) without any apparent increase in risk of cancer, blood clot or stroke.